If confirmed in larger studies.

I with with Chronix further validate further validate these promising results. ‘.. Chronix data presented at ASCO that could revolutionize the diagnostic paradigm for cancerChronix Biomedical today reported a summary of the data that the benefits of its serum DNA blood tests for the early and accurate detection of breast cancer and prostate cancer. The unique testing algorithms developed Chronix detected and correctly identified DNA fragments in the blood of the dying cells with 92 percent sensitivity and 100 percent specificity in both prostate and breast cancers. If confirmed in larger studies, these results would perform significantly better than others receive from the current diagnosis for these cancers.

A growing number of peer-reviewed data that the Chronix DNA-based blood tests to detect recurrence at the earliest stages, and they can patient patient – specific response to treatment. Previous published studies have demonstrated its potential utility in breast cancer and multiple sclerosis. In conjunction with the University of Calgary, Chronix is also developing commercial applications for veterinary use, including tests for the early detection of BSE , or mad cow disease. Patient care.’With these encouraging results, we are launching a ‘For Investigational Use Only’laboratory – based testing service that for the first time enable cancer researchers to monitor the status of patients in their clinical trials with a high sensitivity and specificity, ‘said Howard Urnovitz, CEO of Chronix ‘This new service provides a unique opportunity clinical research clinical researchers and simultaneously used to expand the data base for the approval for the use of our tests in the current patient care.The low profile design can be because metabolic syndrome is not a disease but a group of illnesses of the your body’s metabolism – including hypertension, elevated blood sugar, overweight and abnormal lipid levels of.

Whilst the obesity epidemic garners headline, you no hear of metabolic syndrome. But these health hazard regards 47 million adults in the U.S., after of the Women July issue of Mayo Clinic Health Source.